NAPLEX (North American Pharmacist Licensure Examination) Practice Exam

For atrial fibrillation, the therapeutic range of Digoxin is typically considered to be 0.8-2 ng/mL. This range is chosen because it provides the desired therapeutic effect while minimizing the risk of toxicity. It is important to monitor the Digoxin levels regularly in patients to ensure they are within this therapeutic range.

Options A, C, and D are not correct because they fall outside of the generally accepted therapeutic range for Digoxin in atrial fibrillation. It is crucial for healthcare professionals to be familiar with the appropriate therapeutic ranges for different medications, as this knowledge is essential for optimizing patient outcomes and minimizing adverse effects.